alexa
Reach Us +441704335730
Metastatic Colorectal Cancer: Review of Diagnosis and Treatment Options | OMICS International | Abstract
[Jurnalul de Chirurgie]
ISSN: 1584-9341

Journal of Surgery
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Review Article

Metastatic Colorectal Cancer: Review of Diagnosis and Treatment Options

Madalina Palaghia1*, Cristina Cijevschi Prelipcean2, Elena Cotea3, Nuțu Vlad1, Lucian Leneschi3, Valentin Bejan3, Lacramioara Perianu1, Alin Vasilescu1 and Eugen Târcoveanu1

1Department of Surgery, First Surgical Unit “St. Spiridon” Hospital Iasi, University of Medicine and Pharmacology “Gr.T. Popa” Iasi, Romania

2Department of Gastroenterology, University of Medicine and Pharmacy “Gr.T. Popa” Iasi, Romania

3First Surgical Unit “St. Spiridon” Hospital Iasi, Romania

*Corresponding Author:
Madalina Palaghia, MD
Department of Surgery, First Surgical Unit
“St. Spiridon” Hospital, Iași, Romania
Bd. Independenței, No 1,700111, Iași, Romania
Tel: +40 (0) 0232-24 08 22
Fax: +40 (0) 0232-21 77 81
E-mail: [email protected]

Received Date: May 20, 2014; Accepted Date: July 15, 2014; Published Date: December 28, 2014

Citation: Palaghia M, Prelipcean CC, Cotea E, Vlad N, Leneschi L, et al. Metastatic Colorectal Cancer: Review of Diagnosis and Treatment Options. Journal of Surgery [Jurnalul de chirurgie] 2015; 10(4):249-256 doi:10.7438/1584-9341-10-4-2

Copyright: © 2015 Palaghia M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Colorectal cancer (CRC) is currently considered the third most common neoplasm in the world according to the World Cancer Research Fund International with 1.4 million cases diagnosed in 2012, and the second malignity as cause of death. Approximately 1/5 of patients present directly with metastatic disease (mCRC), and 30 to 50% develop metastasis after surgical treatment for initially localized disease. The aims of the current study are to review the diagnostic particularities, treatment options and clinical evolution of mCRC. Metastatic process in CRC is long and complex, involving several mechanisms, molecular pathways and cellular types. Advances in medical imaging now allow an early and accurate diagnosis of metastatic lesions no matter their location. The progress of fundamental research in CRC led to understanding the molecular basis of the metastatic process that was further translated into novel chemotherapic and biological agents, thus increasing overall survival and and progression-free survival rates. Resection of liver, lung and brain metastases is crucial for survival when achievable and is more effective when completed by an oncological treatment and rigorous follow-up. All patients with mCRC should be discussed by a multidisciplinary team (surgeon, oncologist, radiologist, and gastroenterologist) in order to identify the most appropriate therapeutic management.

Keywords

Top